Add Your Voice to LymphLink
Beginning in 2026 for each quarter, the National Lymphedema Network will elevate our standard monthly newsletter into a dedicated LymphLink edition - an expanded publication designed to deliver high‑quality educational content to the lymphedema community.

These issues feature:

🔑 In‑depth research highlights
🔑 Timely clinical insights
🔑 Educational articles curated for both clinicians and patients

Share Your Expertise with the Lymphatic Community
The National Lymphedema Network welcomes clinicians, researchers, educators, and community members to contribute to LymphLink Each edition highlights meaningful stories, evidence‑informed insights, and real‑world experiences that strengthen understanding and advance care across the lymphatic community.

We invite you to submit:
  • Clinical articles that translate knowledge into practice
  • Research reviews that make current evidence accessible
  • Case studies that illuminate challenges and breakthroughs
  • Community Champion nominations that celebrate individuals making a difference
Your voice helps shape a richer, more connected, and more informed community. Whether you are sharing new findings, elevating patient stories, or highlighting innovative approaches, your contribution supports NLN’s mission to expand awareness and improve care for all those affected by lymphatic conditions.

Submit your work and help us inspire, educate, and empower the community.

2026 Publication Dates & Submission Deadlines
LymphLink Edition Publication Dates
March 12

June 11

September 10

December 3
Submission Deadlines
February 26

May 28

August 27

November 19

Article & Research Review Submission Guidelines
Purpose & Focus
  • Submissions must be educational and evidence‑based, offering clinical insights, research summaries, or care strategies relevant to lymphatic health.
Evidence & Citations
  • All content must be supported by current evidence.
  • A reference list citing the sources used is required.
Authorship
  • Articles may be authored by clinicians, educators, researchers, or other subject‑matter experts.
Tone & Accessibility
  • Professional and accessible to a mixed audience of clinicians, patients, and caregivers
  • Free of promotional or marketing language
Length
  • 600–1,000 words preferred
Optional Visuals
  • Infographics, charts, or other visuals that support learning
  • All visuals are subject to NLN review and approval
Review & Evaluation
Your article will be reviewed by the NLN to ensure it aligns with our educational standards, mission, and publication guidelines.

Notification of Acceptance
You will receive an email notification once a decision has been made.
If your article is accepted, the message will include:
  • Your assigned publication edition (if applicable)
  • Any requested edits or clarifications
  • Final steps and timelines for publication
Revisions (If Needed)
Some submissions may require minor edits for clarity, formatting, or alignment with NLN style. If revisions are requested, please return the updated version by the deadline provided in your acceptance email.

Final Approval
Once revisions are complete, you will receive a final confirmation that your article has been approved for publication.

Publication
Accepted articles will appear in the designated LymphLink edition and will be archived on lymphnet.org for ongoing community access.


Complete the form below
Shine a Light on a Lymphatic Leader
Nominate someone in your community who you think deserves to be recognized, either a healthcare professional or someone living with lymphatic disease, for the positive changes they are making in the world of lymphedema. Complete the form below.

Authorship & Originality

  • I confirm that this submission is my original work and that I have the right to publish it.
  • I confirm that all sources, data, and quotations are properly cited.
  • I confirm that this article has not been previously published elsewhere, unless disclosed to the NLN.

Accuracy & Educational Integrity

  • I confirm that the information provided is accurate, evidence‑informed, and aligned with current clinical standards.
  • I confirm that this submission is educational in nature and does not promote specific products, services, or companies.

Permissions & Rights

  • I grant the NLN permission to edit the article for clarity, length, formatting, and alignment with LymphLink style guidelines.
  • I grant the NLN the right to publish this article in LymphLink and archive it on lymphnet.org.
  • I confirm that any images, charts, or graphics included are either original or used with proper permission.

Confidentiality & Ethics

  • I confirm that no patient‑identifying information is included unless proper consent has been obtained.
  • I confirm that this submission adheres to ethical standards for clinical communication and patient privacy.

Review Process

  • I understand that submission does not guarantee publication.
  • I understand that revisions may be requested before final acceptance.

Conflict of Interest

  • I disclose any financial or professional relationships that may represent a conflict of interest.
  • I confirm that any potential conflicts have been clearly stated within the submission.

Contact Us

National Lymphedema Network
2229 Bridge Avenue #667
Point Pleasant, NJ 08742
(800)-541-3259
nln@lymphnet.org

Patient Support Team

800-541-3259
patientsupport@lymphnet.org

All contents © 2025 National Lymphedema Network. All rights reserved. Use of this and other NLN associated websites and platforms constitutes acceptance of our Terms and Conditions.

Connect with Us